Stock Information
Catalyst Pharmaceuticals Inc (CPRX)
Ticker Symbol: CPRX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,034.71 mil
Piotroski score: 4
PE Ratio: 16.3933
EPS (TTM): 1.6844
Revenue (TTM): $4.62 M
Dividend Yield: N/A%
ROE: 24.32%
Latest News
-
Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026
Tue, Apr 28, 2026 8:03 AM
-
Angelini Pharma Reportedly Explores A Potential Acquisition of Catalyst Pharmaceuticals
Mon, Apr 27, 2026 4:50 PM
-
Catalyst Pharmaceuticals shares are trading higher following a report suggesting that Italian drugmaker Angelini Pharma is exploring a potential acquisition of the company.
Mon, Apr 27, 2026 12:38 PM
-
Italy's Angelini said to explore acquisition of Catalyst Pharma - Bloomberg News
Mon, Apr 27, 2026 12:32 PM
-
UPDATE: 'Italy's Angelini Said to Explore Acquisition of Catalyst Pharma' - Bloomberg News
Mon, Apr 27, 2026 12:30 PM
-
Watching Catalyst Pharmaceuticals; Traders Circulate Unconfirmed Rumor The Company Is Seeing Takeover Interest
Mon, Apr 27, 2026 12:10 PM
-
Catalyst Pharmaceuticals: Favorable Trial Outcome Could Be A Meaningful Overhang
Sun, Apr 26, 2026 11:59 PM
Key Financials
Financial data not available
